BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 16136016)

  • 1. Treatment of acute agitation in psychotic disorders.
    Mohr P; Pecenák J; Svestka J; Swingler D; Treuer T
    Neuro Endocrinol Lett; 2005 Aug; 26(4):327-35. PubMed ID: 16136016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S
    J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New formulations of olanzapine in the treatment of acute agitation].
    Bartkó G
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):171-8. PubMed ID: 17211052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I; Preval H; Southard R; Francis A
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study.
    Lim HK; Kim JJ; Pae CU; Lee CU; Lee C; Paik IH
    Neuropsychobiology; 2010; 62(2):81-6. PubMed ID: 20523078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedation in acute and chronic agitation.
    Levy RH
    Pharmacotherapy; 1996; 16(6 Pt 2):152S-159S; discussion 166S-168S. PubMed ID: 8947999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of agitation in the acute psychotic patient--efficacy without excessive sedation.
    Cañas F
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S108-14. PubMed ID: 17336765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Now take a deep breath: inhaled loxapine for the treatment of acute agitation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Jan; 50(1):16-8. PubMed ID: 22229963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best clinical practice with ziprasidone IM: update after 2 years of experience.
    Zimbroff DL; Allen MH; Battaglia J; Citrome L; Fishkind A; Francis A; Herr DL; Hughes D; Martel M; Preval H; Ross R
    CNS Spectr; 2005 Sep; 10(9):1-15. PubMed ID: 16247923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of psychotic agitation.
    Currier GW; Trenton A
    CNS Drugs; 2002; 16(4):219-28. PubMed ID: 11945106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
    Daniel DG; Potkin SG; Reeves KR; Swift RH; Harrigan EP
    Psychopharmacology (Berl); 2001 May; 155(2):128-34. PubMed ID: 11401000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risks associated with parenteral treatment of acute agitation].
    Boomsma MM; Mengels O; van Olden RW
    Tijdschr Psychiatr; 2006; 48(2):135-9. PubMed ID: 16958197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological management of acute agitation.
    Battaglia J
    Drugs; 2005; 65(9):1207-22. PubMed ID: 15916448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical perspectives on atypical antipsychotics for treatment of agitation.
    Caine ED
    J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benzodiazepines, typical and atypical antipsychotics in the management of acute agitation: a review].
    Yildiz A
    Turk Psikiyatri Derg; 2003; 14(2):134-44. PubMed ID: 12844280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing the agitated psychotic patient: a reappraisal of the evidence.
    Allen MH
    J Clin Psychiatry; 2000; 61 Suppl 14():11-20. PubMed ID: 11154012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
    Lesem MD; Zajecka JM; Swift RH; Reeves KR; Harrigan EP
    J Clin Psychiatry; 2001 Jan; 62(1):12-8. PubMed ID: 11235922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.